The company will showcase the evolving role of vitamins and lipid APIs in pharmaceutical applications at CPhI Worldwide 2018.
DSM, a supplier of vitamins, carotenoids, and lipid APIs, will exhibit its portfolio of vitamins and lipid APIs at CPhI Worldwide, taking place in Madrid, Spain on Oct. 9–11, 2018.
The company’s pipeline is focused on addressing the latest research on the therapeutic effects of vitamins, as well as the development of vitamin combinations with established APIs. While combinations such as nonsteroidal anti-inflammatory drugs with B vitamins and contraceptives with folate are commercially available in several countries, DSM brings vitamin combinations to market for indications such as chronic low back pain, osteoarthritis, hypertension, type 2 diabetes, inflammatory bowel disease, and ulcer treatment.
DSM can provide access to both United States drug master files and certificates of suitability for all 13 of its vitamins, providing its pharmaceutical partners an advantage by accelerating the registration and market entry process, which enables timelier patient access, the company reports.
The company’s expertise in chemical synthesis and biotechnology helps to ensure products meet sustainability standards. Learn more at Stand 7B10 at 4pm–6pm on Oct. 9 and 10 at CPhI Worldwide 2018.
